NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

COMMON STOCK WARRANTS (Details Narrative)

v2.4.0.8

COMMON STOCK WARRANTS (Details Narrative) (USD $)	9 Months Ended								0 Months Ended				9 Months Ended									9 Months Ended
COMMON STOCK WARRANTS (Details Narrative) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 25, 2014	May 30, 2014	Apr. 08, 2014	Mar. 26, 2014	Oct. 31, 2013	Oct. 02, 2013	Jan. 07, 2014 Warrants [Member]	Jan. 02, 2014 Warrants [Member]	Dec. 30, 2013 Warrants [Member]	Oct. 02, 2013 Warrants [Member]	Jun. 30, 2014 Warrants [Member]	Jun. 25, 2014 Warrants [Member]	Apr. 16, 2014 Warrants [Member]	Apr. 08, 2014 Warrants [Member]	Mar. 31, 2014 Warrants [Member]	Mar. 26, 2014 Warrants [Member]	Feb. 25, 2014 Warrants [Member]	Oct. 31, 2013 Warrants [Member]	Sep. 30, 2013 Warrants [Member]	Jun. 30, 2014 Warrants [Member] Lower Range [Member[	Jun. 30, 2014 Warrants [Member] Upper Range [Member]
Fair Value assumptions:
Stock price				$ 8.52	$ 10.00			$ 7.96														$ 7.85	$ 7.96
Expected term																						2 years	5 years
Exercise Price																						$ 7.88	$ 7.96
Risk free interest rate																						0.38%	1.72%
Dividend yield													0.00%
Volatility rate																						98.00%	163.00%
Warrants outstanding									100,000	20,550	26,667	100,000									5,860,934
Warrants issued for services		$ 214,500							$ 390,852	$ 150,665	$ 65,748	$ 481,724
Warrant exercise price			$ 1.20			$ 1.50	$ 3.60		$ 7.94	$ 7.88	$ 7.94	$ 7.96		$ 1.20	$ 1.60	$ 3.60	$ 2.51	$ 1.50	$ 10.00	$ 3.60	$ 2.77
Warrant term									3 years	5 years	2 years	3 years
Consulting Expense, as recorded in professional fees	1,078,669
Vesting terms									25,000 warrants vested immediately, with the remainder vesting over the next three quarterly periods	Vest immediately	Vest immediately	Vest immediately
Warrants vested									25,000	20,550	26,667	100,000
Award vesting period									9 months
Intrinsic value of warrants	$ 23,900,000

- Definition

Expense amounts recorded in professional fees expense for consulting services provided. In lieu of cash, warrants to purchase shares of company stock were issued in these transactions.

+ References

No definition available.

+ Details

Name:	ohrp_ConsultingExpensePFNoncash
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Intrinsic value of warrants outstanding.

+ References

No definition available.

+ Details

Name:	ohrp_WarrantsAggregateIntrinsicValueOutstanding
Namespace Prefix:	ohrp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The contractual term of warrants.

+ References

No definition available.

+ Details

Name:	ohrp_WarrantTerm
Namespace Prefix:	ohrp_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Agreed upon price for the exchange of the underlying asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssumptionsExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).

+ References

+ Details

Name:	us-gaap_FairValueAssumptionsExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_FairValueAssumptionsExpectedTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.

+ References

+ Details

Name:	us-gaap_FairValueAssumptionsExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Risk-free interest rate assumption used in valuing an instrument.

+ References

+ Details

Name:	us-gaap_FairValueAssumptionsRiskFreeInterestRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name:	us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale. For example, vesting may be expressed as being 25 percent of the shares under option on each anniversary of the grant date.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant